Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 12.12 is 55% above its 5-year average of 7.81, around the middle of its 5-year range (0.00–17.85).
As of the fiscal period ended Tuesday, June 30, 2026. 9.10% below its 12-month average of 13.33.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 12.12.
CURRENT RATIO
12.12
CURRENT RATIO AVG TTM
13.33
CURRENT RATIO AVG 3Y
9.30
CURRENT RATIO AVG 5Y
7.81
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.10%
CURRENT VS 3Y AVG
+30.29%
CURRENT VS 5Y AVG
+55.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.09
median of 448 covered companies
CURRENT VS SECTOR MEDIAN
+292.23%
vs the sector median at left
Amylyx Pharmaceuticals, Inc.
Market Cap
$3.09B
Current Ratio
12.12
TTM Avg
13.33
3Y Avg
9.30
5Y Avg
7.81
Market Cap
$3.15B
Current Ratio
2.92
TTM Avg
3.66
3Y Avg
6.49
5Y Avg
8.50
Market Cap
$3.25B
Current Ratio
64.07
TTM Avg
24.32
3Y Avg
16.73
5Y Avg
16.77
Market Cap
$2.88B
Current Ratio
12.02
TTM Avg
18.93
3Y Avg
12.46
5Y Avg
15.83
Market Cap
$3.44B
Current Ratio
3.39
TTM Avg
3.10
3Y Avg
3.17
5Y Avg
4.31
Market Cap
$2.69B
Current Ratio
1.16
TTM Avg
1.32
3Y Avg
1.06
5Y Avg
0.97
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | $3.09B | 12.12 | 13.33 | 9.30 | 7.81 |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 2.92 | 3.66 | 6.49 | 8.50 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | 8.37 | 8.81 | 8.76 | 9.71 |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | 64.07 | 24.32 | 16.73 | 16.77 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 12.02 | 18.93 | 12.46 | 15.83 |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 6.62 | 7.72 | 8.85 | 8.81 |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 4.22 | 3.80 | 3.72 | 4.10 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 3.39 | 3.10 | 3.17 | 4.31 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 1.16 | 1.32 | 1.06 | 0.97 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 1.57 | 1.27 | 1.13 | 1.28 |
Current Ratio
12.12
Quick Ratio
12.12
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 12.12 |
| 2026-03-31 | 17.85 |
| 2025-12-31 | 14.27 |
| 2025-09-30 | 13.70 |
| 2025-06-30 | 8.72 |
| 2025-03-31 | 12.05 |
| 2024-12-31 | 6.67 |
| 2024-09-30 | 4.55 |
| 2024-06-30 | 4.66 |
| 2024-03-31 | 4.48 |
| 2023-12-31 | 5.66 |
| 2023-09-30 | 9.52 |
| 2023-06-30 | 6.67 |
| 2023-03-31 | 7.54 |
| 2022-12-31 | 8.20 |
| 2022-09-30 | 5.27 |
| 2022-06-30 | 7.96 |
| 2022-03-31 | 9.58 |
| 2021-12-31 | 6.03 |
| 2021-09-30 | 8.58 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
